One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage Plus membership.
Explore Editage Plus
Audio Papers
Ask R Discovery
Translation
Auto-sync
Collaboration
Open Accesshttps://doi.org/10.1182/blood-2020-138391
Copy DOI
Export
Save
Share
Cite Journal: Blood |  Publication Date: Nov 5, 2020 |
Affiliation: Complejo Hospitalario de Salamanca, Medical College and Hospital, Kolkata, University Hospitals of Leicester NHS Trust, Baylor University Medical Center, Institute of Blood Pathology and Transfusion Medicine of the National Academy of Medical Sciences of Ukraine, Evangelismos Hospital, Centre Hospitalier Universitaire de Poitiers, Norton Healthcare, National Cancer Institute, Karyopharm Therapeutics (United States), King's College Hospital NHS Foundation Trust, Centre Hospitalier Universitaire de Lille, University of Lille, Dana-Farber Cancer Institute, St Vincent's Hospital, Cherkasy State Technological University, National and Kapodistrian University of Athens, Alexandra Hospital, Indira Gandhi Institute of Medical Sciences, University of Alberta, Centre Hospitalier Universitaire de Nantes, Medical University of Silesia, University of Calgary, Institute of Cancer Research, Icahn School of Medicine at Mount Sinai, Imperial College Healthcare NHS Trust, University Hospital Ostrava, University Hospital Brno, City Clinical Hospital, University of Bologna, Southwestern Medical Center, The University of Texas Southwestern Medical Center, Charles University, University of Maryland, Baltimore
Effect of Prior Treatment with Proteasome Inhibitors on the Efficacy and Safety of Once-Weekly Selinexor, Bortezomib, and Dexamethasone in Comparison with Twice-Weekly Bortezomib and Dexamethasone in Relapsed or Refractory Multiple Myeloma: Subgroup Analysis from the Boston Study
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
